Condition
Chemotherapy-induced Peripheral Neuropathy
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 25 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
25 shownTranscutaneous Electrical Acupoint Stimulation on Symptoms Associated with Chemotherapy Induced Peripheral NeuropathyNCT05904340 · 2023-07-01
RECRUITINGNeurocognitive and Psychological Impact of Chemotherapy in Breast Cancer Patients: A Prospective Observational StudyNCT07184749 · 2025-10-01
NOT_YET_RECRUITINGEvaluation of Hydroxychloroquine to Prevent CIPNNCT05689359 · 2024-06-01
WITHDRAWNPaclitaxel-induced Polyneuropathy in Breast Cancer: Early Detection, Risk Factors, Quality of Life and Lifestyle OutcomesNCT06052345 · 2024-03-31
WITHDRAWNSymptoms Associated with Chemotherapy-Induced Peripheral NeuropathyNCT06352567 · 2024-01-18
COMPLETEDThe Mamma HiToP StudyNCT06132776 · 2023-11-03
UNKNOWNRole of Curcumin in Paclitaxel Induced PNNCT05966441 · 2023-08-30
UNKNOWNThe AIUR Trial: Surgical Gloves to Prevent Peripheral NeuropathyNCT05771974 · 2023-06-13
ACTIVE_NOT_RECRUITINGThe Effect of Cryotherapy on Breast Cancer PatientsNCT06020222 · 2023-05-01
UNKNOWNPreventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial)NCT05528263 · 2022-09-08
COMPLETEDCIPN in Early Stage Breast Cancer PatientsNCT05441722 · 2022-05-26
UNKNOWNRisk Prediction of Taxane Chemotherapy-Induced Peripheral NeuropathyNCT04932031 · 2022-05-25
TERMINATEDChemotherapy-induced Peripheral Neuropathy (CIPN) on Motor and Sensory FunctionNCT04799080 · 2021-03-06
COMPLETEDLidocaine Versus Duloxetine for the Prevention of Taxane-Induced Peripheral Neuropathy In Breast Cancer PatientsNCT04732455 · 2021-01-15
COMPLETEDHome-Based Physical Activity Intervention for Taxane-Induced CIPNNCT04621721 · 2020-08-14
UNKNOWNEffect of Hemp-CBD on Patients With CIPNNCT04398446 · 2020-05-27
UNKNOWNCryotherapy vs. Cryocompression for Preventing Chemotherapy-induced-peripheral-neuropathy in Women Undergoing ChemotherapyNCT04632797 · 2020-02-03
UNKNOWNNR in Chemo-induced Peripheral NeuropathyNCT03642990 · 2019-11-08
TERMINATEDAcupuncture Treatment of Chemotherapy-Induced Peripheral Neuropathy in WomenNCT04067544 · 2019-11-05
TERMINATEDCIPN-prevention Trial Evaluating the Efficacy of Hand-cooling and Hand-compressionNCT06541769 · 2019-10-15
COMPLETEDPain, Psychological, and Endocannabinoid Responses to Yoga in Breast Cancer Survivors With Chemotherapy-induced Neuropathic PainNCT04075097 · 2019-07-31
COMPLETEDInvolvement of SK3 Calcium Channel in Taxane NeuropathyNCT03816904 · 2019-02-06
COMPLETEDAcupuncture on Chemotherapy-induced Peripheral NeuropathyNCT03626220 · 2018-06-27
COMPLETEDChemotherapy Induced Peripheral Neuropathy (CIPN)NCT03272919 · 2017-09-28
COMPLETEDChemotherapy-Induced Peripheral Neuropathy SurveyNCT01016028 · 2009-11-01
WITHDRAWNCommon interventions
AcupunctureDEVICE2acupunctureOTHER1Aerobic exerciseBEHAVIORAL1Arm 1: Investigational INFOTHER1Arm 2: standardized muscle stretching and strengthOTHER1Blood samplesOTHER1Compression therapy using surgical glovesDEVICE1cryotherapyDEVICE1CurcuminDIETARY_SUPPLEMENT1Duloxetine 30 MGDRUG1educationOTHER1European Organization for Research and Treatment of Cancer-Chemotherapy Induced Peripheral Neuropathy (EORTC-CIPN20) questionnaireOTHER1Exercise prehabilitationBEHAVIORAL1Gait/balance & resistive exerciseBEHAVIORAL1Garmin smartwatchDEVICE1Hemp-based CBDDRUG1Hilotherm Chemo CareDEVICE1HiToP 191 PNPDEVICE1HydroxychloroquineDRUG1InterviewBEHAVIORAL1Iyengar yogaBEHAVIORAL1Lidocaine in SalineDRUG1Limb compressionDEVICE1Limb hypothermiaDEVICE1Nature scenery with a relaxation exerciseOTHER1
Leading sponsors
Izmir Bakircay University
2
Ain Shams University
1
China Medical University Hospital
1
Dana-Farber Cancer Institute
1
Donna Hammond, PhD
1
Gamal Mohamed Taha Abouelmagd
1
Kaohsiung Medical University Chung-Ho Memorial Hospital
1
Loma Linda University
1
M.D. Anderson Cancer Center
1
Main Line Health
1
Medical University Innsbruck
1
National Taipei University of Nursing and Health Sciences
1
Northumbria University
1
Sapere Bio
1
Sohag University
1
Trial status mix
COMPLETED9
UNKNOWN7
TERMINATED3
WITHDRAWN3
ACTIVE_NOT_RECRUITING1
NOT_YET_RECRUITING1
RECRUITING1
Phase mix
NA14
PHASE24
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.